Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Zurex Pharma Inc.
DescriptionProprietary antimicrobial
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Infectious (unspecified)
Indication DetailsPrevent intra-luminal catheter related blood stream infections (CRBSI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today